HBS1L Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9Y450 |
---|---|
Clone Names | 110826182 |
Gene ID | 10767 |
---|---|
Other Names | HBS1-like protein, ERFS, HBS1L, HBS1, KIAA1038 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | HBS1L {ECO:0000303|PubMed:28204585, ECO:0000312|HGNC:HGNC:4834} |
---|---|
Function | GTPase component of the Pelota-HBS1L complex, a complex that recognizes stalled ribosomes and triggers the No-Go Decay (NGD) pathway (PubMed:21448132, PubMed:23667253, PubMed:27863242). The Pelota-HBS1L complex recognizes ribosomes stalled at the 3' end of an mRNA and engages stalled ribosomes by destabilizing mRNA in the mRNA channel (PubMed:27863242). Following mRNA extraction from stalled ribosomes by the SKI complex, the Pelota-HBS1L complex promotes recruitment of ABCE1, which drives the disassembly of stalled ribosomes, followed by degradation of damaged mRNAs as part of the NGD pathway (PubMed:21448132, PubMed:32006463). |
Cellular Location | Cytoplasm. |
Tissue Location | Detected in heart, brain, placenta, liver, muscle, kidney and pancreas. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a member of the GTP-binding elongationfactor family. It is expressed in multiple tissues with the highestexpression in heart and skeletal muscle. The intergenic region ofthis gene and the MYB gene has been identified to be a quantitativetrait locus (QTL) controlling fetal hemoglobin level, and thisregion influnces erythrocyte, platelet, and monocyte counts as wellas erythrocyte volume and hemoglobin content. DNA polymorphisms atthis region associate with fetal hemoglobin levels and pain crisesin sickle cell disease. A single nucleotide polymorphism in exon 1of this gene is significantly associated with severity inbeta-thalassemia/Hemoglobin E. Multiple alternatively splicedtranscript variants encoding different protein isoforms have beenfound for this gene.
References
Nuinoon, M., et al. Hum. Genet. 127(3):303-314(2010)Kamatani, Y., et al. Nat. Genet. 42(3):210-215(2010)Nuinoon, M., et al. Hum. Genet. (2009) In press :Ganesh, S.K., et al. Nat. Genet. 41(11):1191-1198(2009)Ferreira, M.A., et al. Am. J. Hum. Genet. 85(5):745-749(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.